Biotech IP Monetization Platforms Market Size, Share, and Trends 2025 to 2034

The biotech IP monetization platforms market is growing as biotech firms seek to maximize returns from intellectual property through licensing, partnerships, and royalty deals. These platforms facilitate the commercialization of biotech innovations and patents. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

Last Updated : July 2025  |  Report Code : 6439  |  Category : ICT  |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Biotech IP Monetization Platforms Market 

5.1. COVID-19 Landscape: Biotech IP Monetization Platforms Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Biotech IP Monetization Platforms Market, By Type of Monetization Strategy

8.1. Biotech IP Monetization Platforms Market, by Type of Monetization Strategy

8.1.1. Licensing Platforms (Inbound & Outbound Licensing)

8.1.1.1. Market Revenue and Forecast

8.1.2. Royalty Monetization & Royalty Financing

8.1.2.1. Market Revenue and Forecast

8.1.3. Patent Brokerage & Auctions

8.1.3.1. Market Revenue and Forecast

8.1.4. Patent Pools & Cross-Licensing Hubs

8.1.4.1. Market Revenue and Forecast

8.1.5. IP-Backed Debt & Securitization

8.1.5.1. Market Revenue and Forecast

8.1.6. Technology Transfer Platforms

8.1.6.1. Market Revenue and Forecast

8.1.7. M&A & Asset Divestiture Matchmaking

8.1.7.1. Market Revenue and Forecast

8.1.8. Tokenization & Blockchain-Based IP Monetization

8.1.8.1. Market Revenue and Forecast

Chapter 9. Global Biotech IP Monetization Platforms Market, By Type of IP Asset Handled

9.1. Biotech IP Monetization Platforms Market, by Type of IP Asset Handled

9.1.1. Patents

9.1.1.1. Market Revenue and Forecast

9.1.2. Trade Secrets

9.1.2.1. Market Revenue and Forecast

9.1.3. Know-How & Technical Dossiers

9.1.3.1. Market Revenue and Forecast

9.1.4. Genetic Sequences/Data Sets

9.1.4.1. Market Revenue and Forecast

9.1.5. Software/Algorithms (Bioinformatics/AI)

9.1.5.1. Market Revenue and Forecast

9.1.6. Trademarks & Brands

9.1.6.1. Market Revenue and Forecast

9.1.7. Copyrighted Research Tools

9.1.7.1. Market Revenue and Forecast

Chapter 10. Global Biotech IP Monetization Platforms Market, By Platform Model 

10.1. Biotech IP Monetization Platforms Market, by Platform Model

10.1.1. Marketplace Platforms (Online IP Exchanges)

10.1.1.1. Market Revenue and Forecast

10.1.2. Advisory & Analytics Platforms

10.1.2.1. Market Revenue and Forecast

10.1.3. Royalty Investment Platforms

10.1.3.1. Market Revenue and Forecast

10.1.4. Hybrid (Marketplace + Services)

10.1.4.1. Market Revenue and Forecast

Chapter 11. Global Biotech IP Monetization Platforms Market, By End-User

11.1. Biotech IP Monetization Platforms Market, by End-User

11.1.1. Biotech Startups & SMEs

11.1.1.1. Market Revenue and Forecast

11.1.2. Large Biopharma Companies

11.1.2.1. Market Revenue and Forecast

11.1.3. Universities & Research Institutions

11.1.3.1. Market Revenue and Forecast

11.1.4. IP Holding Firms (Patent Aggregators)

11.1.4.1. Market Revenue and Forecast

11.1.5. Venture Capital & Royalty Investment Funds

11.1.5.1. Market Revenue and Forecast

Chapter 12. Global Biotech IP Monetization Platforms Market, By Application Area

12.1. Biotech IP Monetization Platforms Market, by Application Area

12.1.1. Drug Discovery & Development

12.1.1.1. Market Revenue and Forecast

12.1.2. Gene & Cell Therapy

12.1.2.1. Market Revenue and Forecast

12.1.3. Diagnostics & Biomarkers

12.1.3.1. Market Revenue and Forecast

12.1.4. Digital Health & Bioinformatics

12.1.4.1. Market Revenue and Forecast

12.1.5. Biomanufacturing

12.1.5.1. Market Revenue and Forecast

12.1.6. Agricultural Biotech

12.1.6.1. Market Revenue and Forecast

12.1.7. Synthetic Biology

12.1.7.1. Market Revenue and Forecast

Chapter 13. Global Biotech IP Monetization Platforms Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Type of Monetization Strategy

13.1.2. Market Revenue and Forecast, by Type of IP Asset Handled

13.1.3. Market Revenue and Forecast, by Platform Model

13.1.4. Market Revenue and Forecast, by End-User  

13.1.5. Market Revenue and Forecast, by Application Area

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Type of Monetization Strategy

13.1.6.2. Market Revenue and Forecast, by Type of IP Asset Handled

13.1.6.3. Market Revenue and Forecast, by Platform Model

13.1.6.4. Market Revenue and Forecast, by End-User  

13.1.6.5. Market Revenue and Forecast, by Application Area  

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Type of Monetization Strategy

13.1.7.2. Market Revenue and Forecast, by Type of IP Asset Handled

13.1.7.3. Market Revenue and Forecast, by Platform Model

13.1.7.4. Market Revenue and Forecast, by End-User  

13.1.7.5. Market Revenue and Forecast, by Application Area

13.2. Europe

13.2.1. Market Revenue and Forecast, by Type of Monetization Strategy

13.2.2. Market Revenue and Forecast, by Type of IP Asset Handled

13.2.3. Market Revenue and Forecast, by Platform Model

13.2.4. Market Revenue and Forecast, by End-User   

13.2.5. Market Revenue and Forecast, by Application Area  

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Type of Monetization Strategy

13.2.6.2. Market Revenue and Forecast, by Type of IP Asset Handled

13.2.6.3. Market Revenue and Forecast, by Platform Model

13.2.7. Market Revenue and Forecast, by End-User   

13.2.8. Market Revenue and Forecast, by Application Area  

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Type of Monetization Strategy

13.2.9.2. Market Revenue and Forecast, by Type of IP Asset Handled

13.2.9.3. Market Revenue and Forecast, by Platform Model

13.2.10. Market Revenue and Forecast, by End-User  

13.2.11. Market Revenue and Forecast, by Application Area

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Type of Monetization Strategy

13.2.12.2. Market Revenue and Forecast, by Type of IP Asset Handled

13.2.12.3. Market Revenue and Forecast, by Platform Model

13.2.12.4. Market Revenue and Forecast, by End-User  

13.2.13. Market Revenue and Forecast, by Application Area

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Type of Monetization Strategy

13.2.14.2. Market Revenue and Forecast, by Type of IP Asset Handled

13.2.14.3. Market Revenue and Forecast, by Platform Model

13.2.14.4. Market Revenue and Forecast, by End-User  

13.2.15. Market Revenue and Forecast, by Application Area

13.3. APAC

13.3.1. Market Revenue and Forecast, by Type of Monetization Strategy

13.3.2. Market Revenue and Forecast, by Type of IP Asset Handled

13.3.3. Market Revenue and Forecast, by Platform Model

13.3.4. Market Revenue and Forecast, by End-User  

13.3.5. Market Revenue and Forecast, by Application Area

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Type of Monetization Strategy

13.3.6.2. Market Revenue and Forecast, by Type of IP Asset Handled

13.3.6.3. Market Revenue and Forecast, by Platform Model

13.3.6.4. Market Revenue and Forecast, by End-User  

13.3.7. Market Revenue and Forecast, by Application Area

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Type of Monetization Strategy

13.3.8.2. Market Revenue and Forecast, by Type of IP Asset Handled

13.3.8.3. Market Revenue and Forecast, by Platform Model

13.3.8.4. Market Revenue and Forecast, by End-User  

13.3.9. Market Revenue and Forecast, by Application Area

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Type of Monetization Strategy

13.3.10.2. Market Revenue and Forecast, by Type of IP Asset Handled

13.3.10.3. Market Revenue and Forecast, by Platform Model

13.3.10.4. Market Revenue and Forecast, by End-User  

13.3.10.5. Market Revenue and Forecast, by Application Area

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Type of Monetization Strategy

13.3.11.2. Market Revenue and Forecast, by Type of IP Asset Handled

13.3.11.3. Market Revenue and Forecast, by Platform Model

13.3.11.4. Market Revenue and Forecast, by End-User  

13.3.11.5. Market Revenue and Forecast, by Application Area

13.4. MEA

13.4.1. Market Revenue and Forecast, by Type of Monetization Strategy

13.4.2. Market Revenue and Forecast, by Type of IP Asset Handled

13.4.3. Market Revenue and Forecast, by Platform Model

13.4.4. Market Revenue and Forecast, by End-User  

13.4.5. Market Revenue and Forecast, by Application Area

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Type of Monetization Strategy

13.4.6.2. Market Revenue and Forecast, by Type of IP Asset Handled

13.4.6.3. Market Revenue and Forecast, by Platform Model

13.4.6.4. Market Revenue and Forecast, by End-User  

13.4.7. Market Revenue and Forecast, by Application Area

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Type of Monetization Strategy

13.4.8.2. Market Revenue and Forecast, by Type of IP Asset Handled

13.4.8.3. Market Revenue and Forecast, by Platform Model

13.4.8.4. Market Revenue and Forecast, by End-User  

13.4.9. Market Revenue and Forecast, by Application Area

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Type of Monetization Strategy

13.4.10.2. Market Revenue and Forecast, by Type of IP Asset Handled

13.4.10.3. Market Revenue and Forecast, by Platform Model

13.4.10.4. Market Revenue and Forecast, by End-User  

13.4.10.5. Market Revenue and Forecast, by Application Area

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Type of Monetization Strategy

13.4.11.2. Market Revenue and Forecast, by Type of IP Asset Handled

13.4.11.3. Market Revenue and Forecast, by Platform Model

13.4.11.4. Market Revenue and Forecast, by End-User  

13.4.11.5. Market Revenue and Forecast, by Application Area

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Type of Monetization Strategy

13.5.2. Market Revenue and Forecast, by Type of IP Asset Handled

13.5.3. Market Revenue and Forecast, by Platform Model

13.5.4. Market Revenue and Forecast, by End-User  

13.5.5. Market Revenue and Forecast, by Application Area

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Type of Monetization Strategy

13.5.6.2. Market Revenue and Forecast, by Type of IP Asset Handled

13.5.6.3. Market Revenue and Forecast, by Platform Model

13.5.6.4. Market Revenue and Forecast, by End-User  

13.5.7. Market Revenue and Forecast, by Application Area

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Type of Monetization Strategy

13.5.8.2. Market Revenue and Forecast, by Type of IP Asset Handled

13.5.8.3. Market Revenue and Forecast, by Platform Model

13.5.8.4. Market Revenue and Forecast, by End-User  

13.5.8.5. Market Revenue and Forecast, by Application Area

Chapter 14. Company Profiles

14.1. Royalty Pharma

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Ocean Tomo

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. IPwe

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Aon IP Solutions

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. SciFi VC

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Sagacious IP

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Innography (Clarivate)

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Ocean Tomo Bid-Ask™ Market

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. LAVA IP

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. IAM Market

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The major players in the biotech IP monetization platforms market include Royalty Pharma, Ocean Tomo, IPwe, Aon IP Solutions, SciFi VC, Sagacious IP, Innography (Clarivate), Ocean Tomo Bid-Ask™ Market, LAVA IP, IAM Market, KEW Inc, Red Chalk Group, NGB Corporation, IPNav, IPlicensing.net, Allied Security Trust (AST), XOMA Corporation, IPValue, WIPO GREEN (for biotech sustainability IPs), and LexisNexis PatentSight.

The driving factors of the biotech IP monetization platforms market are the growing awareness of importance of intellectual property protection in the biotech industry is driving the growth of the biotech IP monetization platforms market. Rising investments in research and development have increased demand for biotech IP monetization platforms.

North America region will lead the global biotech IP monetization platforms market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client